C-Path Selects Global Regulatory Affairs Leader as New President and CEO

TUCSON, Ariz., March 21, 2019 After a worldwide search, the Critical Path Institute (C-Path) today announced it has appointed Joseph Scheeren, Pharm. D., as its new President and Chief Executive Officer. Scheeren previously served as Senior Advisor Research and Development for Bayer AG and has had a distinguished 36-year career in the pharmaceutical industry having held positions domestically and internationally in drug development and regulatory approval on three continents.

Continue reading

Beacon Biomedical Teams with National Phlebotomy Providers Network  To Launch a Nationwide Blood-Draw Service to Support BeScreened™-CRC

Despite being one of the most preventable cancers, colorectal cancer is the 2nd leading cause of cancer deaths among men and women in the United States. In 2018 alone, there were an estimated 140,250 new cases of colorectal cancer and 50,630 deaths.  While existing screening tests, such as fecal-based tests and colonoscopies, are extremely effective at finding colorectal cancer, they only work if they are used. 

 BeScreened™-CRC provides people the option for an easy, accurate & now convenient Blood Test for CRC Screening.Continue reading